CAMPHOR, CAPSAICIN, MENTHOL

CAMPHOR, CAPSAICIN, MENTHOL was reported 531 times

CAMPHOR, CAPSAICIN, MENTHOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VICTIM OF SPOUSAL ABUSE 2 0.0312
1 INFUSION SITE CYST 1 0.0312
2 THIRD DEGREE CHEMICAL BURN OF SKIN 1 0.0238
3 TESTICULAR INJURY 1 0.0238
4 ROTAVIRUS TEST POSITIVE 1 0.0222
5 ENZYME LEVEL ABNORMAL 2 0.0143
6 MUSCLE TENSION DYSPHONIA 1 0.0125
7 INFUSION SITE STREAKING 1 0.0115
8 INFUSION SITE PARAESTHESIA 1 0.0099
9 CHEMICAL BURN 10 0.0087
10 PARANOID PERSONALITY DISORDER 1 0.0076
11 LARGE INTESTINAL POLYPECTOMY 1 0.0061
12 URINARY RETENTION POSTOPERATIVE 1 0.0061
13 RENAL VASCULAR THROMBOSIS 1 0.0058
14 INFUSION SITE INJURY 1 0.0057
15 DEVICE MAINTENANCE ISSUE 3 0.0051
16 LIPOEDEMA 2 0.0051
17 PATIENT ISOLATION 1 0.0047
18 BENDOPNOEA 1 0.0045
19 ORAL CONTUSION 1 0.0043
20 DEVICE WIRELESS COMMUNICATION ISSUE 1 0.0039
21 BURNS THIRD DEGREE 4 0.0038
22 CATHETERISATION CARDIAC ABNORMAL 1 0.0037
23 CHEMICAL BURNS OF EYE 1 0.0036
24 CARBON DIOXIDE ABNORMAL 1 0.0032
25 SALIVA DISCOLOURATION 1 0.0030
26 GASTROINTESTINAL POLYP 1 0.0030
27 MULTIPLE SCLEROSIS PSEUDO RELAPSE 1 0.0029
28 DIVERTICULITIS INTESTINAL PERFORATED 1 0.0028
29 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0027
30 SENSATION OF BLOOD FLOW 1 0.0026
31 MITRAL VALVE REPLACEMENT 1 0.0025
32 BELLIGERENCE 1 0.0023
33 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 1 0.0022
34 PLICATED TONGUE 1 0.0021
35 VITREOUS DISORDER 1 0.0021
36 EXERCISE LACK OF 1 0.0021
37 ARTIFICIAL CROWN PROCEDURE 1 0.0020
38 SKIN OEDEMA 2 0.0020
39 INFUSION SITE ABSCESS 1 0.0020
40 TRANSPLANT EVALUATION 1 0.0020
41 NASAL ULCER 3 0.0019
42 MEDICAL DEVICE CHANGE 1 0.0019
43 ENZYME ABNORMALITY 1 0.0019
44 STOMA SITE IRRITATION 1 0.0018
45 CHRONIC MYELOID LEUKAEMIA RECURRENT 1 0.0018
46 NAIL INJURY 1 0.0018
47 INFUSION SITE DISCHARGE 3 0.0017
48 BURNS SECOND DEGREE 3 0.0017
49 DEEP BRAIN STIMULATION 1 0.0017
50 SACRAL PAIN 1 0.0016
51 EXCESSIVE CERUMEN PRODUCTION 1 0.0016
52 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 3 0.0016
53 STAPHYLOCOCCAL ABSCESS 1 0.0016
54 SCLERAL DISCOLOURATION 1 0.0015
55 POST PROCEDURAL SEPSIS 1 0.0015
56 INFLAMMATORY PAIN 1 0.0015
57 RHONCHI 2 0.0014
58 INFUSION SITE INFLAMMATION 1 0.0014
59 DERMATITIS DIAPER 1 0.0014
60 GLASSY EYES 1 0.0014
61 CERVICAL RADICULOPATHY 1 0.0014
62 PARASOMNIA 1 0.0014
63 IMMUNISATION REACTION 1 0.0014
64 INFUSION SITE INDURATION 2 0.0013
65 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
66 ALLERGIC COUGH 1 0.0013
67 STOMA SITE HAEMORRHAGE 2 0.0013
68 BLISTER INFECTED 1 0.0013
69 POST-TRAUMATIC NECK SYNDROME 1 0.0012
70 SHOULDER FRACTURE 2 0.0012
71 INFUSION SITE HAEMORRHAGE 4 0.0012
72 GIANT CELL ARTERITIS 1 0.0012
73 GASTROENTERITIS SALMONELLA 1 0.0012
74 INFUSION SITE OEDEMA 1 0.0012
75 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
76 INFECTED BITE 1 0.0012
77 MALIGNANT HYPERTENSION 1 0.0012
78 SPINAL CORD NEOPLASM 1 0.0011
79 OROPHARYNGEAL CANDIDIASIS 1 0.0011
80 CERUMEN IMPACTION 1 0.0011
81 BONE CONTUSION 1 0.0011
82 URINARY TRACT INFECTION ENTEROCOCCAL 1 0.0011
83 NECK MASS 3 0.0011
84 BONE SWELLING 1 0.0010
85 NECK INJURY 3 0.0010
86 APPLICATION SITE BURN 5 0.0010
87 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 1 0.0010
88 THERMAL BURN 7 0.0010
89 BREAST DISCOMFORT 1 0.0010
90 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 1 0.0010
91 RESPIRATORY TRACT IRRITATION 1 0.0010
92 SINUSITIS BACTERIAL 1 0.0009
93 NASAL INFLAMMATION 1 0.0009
94 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
95 TRAUMATIC HAEMATOMA 1 0.0009
96 INFUSION SITE BRUISING 2 0.0009
97 INFUSION SITE MASS 1 0.0009
98 SOFT TISSUE DISORDER 1 0.0009
99 SPINAL COLUMN INJURY 2 0.0009
100 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
101 NECK SURGERY 2 0.0009
102 TONGUE HAEMORRHAGE 1 0.0009
103 SKIN ABRASION 4 0.0008
104 RECTAL PROLAPSE 1 0.0008
105 HAEMATOLOGICAL INFECTION 2 0.0008
106 INFUSION SITE WARMTH 1 0.0008
107 DEVICE INFUSION ISSUE 2 0.0008
108 HYPERPARATHYROIDISM SECONDARY 2 0.0008
109 BLOOD BILIRUBIN ABNORMAL 1 0.0008
110 ADENOCARCINOMA PANCREAS 1 0.0008
111 STOMA SITE INFECTION 1 0.0008
112 WEIGHT BEARING DIFFICULTY 2 0.0007
113 BODY MASS INDEX INCREASED 1 0.0007
114 CARBON DIOXIDE INCREASED 1 0.0007
115 SKIN DEPIGMENTATION 1 0.0007
116 INFUSION SITE RASH 1 0.0007
117 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 1 0.0007
118 INFUSION SITE ERYTHEMA 6 0.0007
119 CONNECTIVE TISSUE DISORDER 1 0.0007
120 JOINT LOCK 2 0.0007
121 GLUTEN SENSITIVITY 1 0.0007
122 BLOOD ELECTROLYTES DECREASED 1 0.0007
123 PULMONARY SEPSIS 1 0.0007
124 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
125 STOMA SITE PAIN 1 0.0007
126 GINGIVAL SWELLING 3 0.0007
127 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1 0.0007
128 PORTAL HYPERTENSION 2 0.0006
129 ORAL MUCOSAL ERYTHEMA 1 0.0006
130 SUBSTANCE USE 1 0.0006
131 PRE-EXISTING CONDITION IMPROVED 4 0.0006
132 MEDICAL DEVICE IMPLANTATION 1 0.0006
133 MEGACOLON 1 0.0006
134 INFUSION SITE SWELLING 4 0.0006
135 PHARYNGEAL PARAESTHESIA 1 0.0006
136 SKIN EROSION 2 0.0006
137 HYPERVOLAEMIA 3 0.0006
138 INJECTION RELATED REACTION 1 0.0006
139 DRUG SCREEN NEGATIVE 1 0.0006
140 FOOD INTERACTION 1 0.0006
141 SEASONAL ALLERGY 8 0.0006
142 INDURATION 1 0.0006
143 ESSENTIAL HYPERTENSION 1 0.0005
144 METASTATIC RENAL CELL CARCINOMA 1 0.0005
145 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
146 PLASMACYTOMA 1 0.0005
147 STOMA SITE ERYTHEMA 1 0.0005
148 PANCREATIC CYST 1 0.0005
149 MOTION SICKNESS 1 0.0005
150 NASAL SEPTUM DEVIATION 1 0.0005
151 DIPLEGIA 1 0.0005
152 CARDIAC DISCOMFORT 1 0.0005
153 CHANGE OF BOWEL HABIT 1 0.0005
154 TONGUE BITING 1 0.0005
155 AKINESIA 1 0.0005
156 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
157 CATHETER SITE ERYTHEMA 1 0.0005
158 BLOOD TESTOSTERONE INCREASED 1 0.0005
159 MUSCLE STRAIN 4 0.0005
160 BIPOLAR I DISORDER 1 0.0005
161 COLONOSCOPY 1 0.0005
162 HAEMATOCRIT INCREASED 1 0.0004
163 INFUSION SITE INFECTION 1 0.0004
164 ROSACEA 2 0.0004
165 SINUS PAIN 1 0.0004
166 VOLVULUS 1 0.0004
167 LIMB OPERATION 2 0.0004
168 PAINFUL RESPIRATION 1 0.0004
169 CARTILAGE INJURY 1 0.0004
170 INFUSION SITE PAIN 5 0.0004
171 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
172 CATHETER SITE PAIN 1 0.0004
173 MULTIPLE ALLERGIES 3 0.0004
174 INJECTION SITE DISCHARGE 2 0.0004
175 CHONDROPATHY 1 0.0004
176 ANORGASMIA 1 0.0004
177 DECUBITUS ULCER 3 0.0004
178 STOMA SITE DISCHARGE 1 0.0004
179 HYPERKERATOSIS 2 0.0004
180 ELECTRIC SHOCK SENSATION 1 0.0004
181 DRUG TOLERANCE DECREASED 1 0.0004
182 RESPIRATORY SYMPTOM 1 0.0004
183 DERMATITIS CONTACT 4 0.0004
184 HYPERTONIC BLADDER 1 0.0003
185 LUMBAR SPINAL STENOSIS 1 0.0003
186 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
187 ATYPICAL PNEUMONIA 1 0.0003
188 BURSITIS 4 0.0003
189 DYSCHEZIA 1 0.0003
190 MUSCULOSKELETAL CHEST PAIN 5 0.0003
191 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
192 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
193 TESTICULAR PAIN 1 0.0003
194 ORTHOPNOEA 1 0.0003
195 APPLICATION SITE VESICLES 2 0.0003
196 PLASMA CELL MYELOMA RECURRENT 1 0.0003
197 INJECTION SITE INFECTION 1 0.0003
198 INABILITY TO AFFORD MEDICATION 3 0.0003
199 BREAST MASS 2 0.0003
200 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
201 GINGIVAL BLEEDING 4 0.0003
202 RIB FRACTURE 6 0.0003
203 CORONARY ARTERY OCCLUSION 4 0.0003
204 HEPATIC FIBROSIS 1 0.0003
205 LYMPHOEDEMA 2 0.0003
206 DEPRESSION SUICIDAL 1 0.0003
207 HANGOVER 1 0.0003
208 JOINT DISLOCATION 3 0.0003
209 SKIN WEEPING 1 0.0003
210 PRODUCT SUPPLY ISSUE 2 0.0003
211 FACIAL BONES FRACTURE 1 0.0003
212 LIVER TRANSPLANT 1 0.0003
213 SPONDYLITIS 1 0.0003
214 RESTLESS LEGS SYNDROME 5 0.0003
215 RECTAL DISCHARGE 1 0.0003
216 NERVE INJURY 3 0.0003
217 FEELING DRUNK 2 0.0003
218 THROAT CLEARING 1 0.0003
219 PARANASAL SINUS DISCOMFORT 1 0.0003
220 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
221 INSURANCE ISSUE 4 0.0003
222 COMMUNICATION DISORDER 1 0.0003
223 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
224 LIMB INJURY 7 0.0003
225 RHINOVIRUS INFECTION 1 0.0003
226 MUSCLE RUPTURE 1 0.0003
227 BRAIN FOG 4 0.0003
228 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
229 BLOOD IRON DECREASED 3 0.0003
230 WRIST FRACTURE 3 0.0003
231 SENSORY LOSS 2 0.0002
232 ENURESIS 1 0.0002
233 MUSCLE TIGHTNESS 4 0.0002
234 HICCUPS 2 0.0002
235 TONGUE DISCOMFORT 1 0.0002
236 PURULENT DISCHARGE 1 0.0002
237 SHOULDER OPERATION 1 0.0002
238 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
239 SCAR 4 0.0002
240 TEARFULNESS 1 0.0002
241 MELANOCYTIC NAEVUS 1 0.0002
242 GLOSSODYNIA 5 0.0002
243 GOUT 4 0.0002
244 ANAL INCONTINENCE 2 0.0002
245 SINUS CONGESTION 3 0.0002
246 URINARY TRACT DISORDER 1 0.0002
247 OROPHARYNGEAL DISCOMFORT 2 0.0002
248 URINE ABNORMALITY 1 0.0002
249 DISEASE COMPLICATION 1 0.0002
250 NEPHROGENIC ANAEMIA 1 0.0002
251 PRODUCT DISTRIBUTION ISSUE 2 0.0002
252 ARTHRITIS INFECTIVE 1 0.0002
253 NECK PAIN 12 0.0002
254 MASS 3 0.0002
255 SPINAL COLUMN STENOSIS 1 0.0002
256 SPUTUM DISCOLOURED 2 0.0002
257 VULVOVAGINAL PAIN 1 0.0002
258 HUMERUS FRACTURE 1 0.0002
259 RASH VESICULAR 1 0.0002
260 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
261 INCORRECT DOSAGE ADMINISTERED 1 0.0002
262 PHARYNGEAL SWELLING 2 0.0002
263 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
264 VITREOUS FLOATERS 2 0.0002
265 BREATH SOUNDS ABNORMAL 1 0.0002
266 LIGAMENT SPRAIN 2 0.0002
267 HEPATIC ENZYME ABNORMAL 1 0.0002
268 SALIVARY HYPERSECRETION 2 0.0002
269 FLUID INTAKE REDUCED 1 0.0002
270 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
271 TOOTH ABSCESS 2 0.0002
272 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
273 TENDONITIS 3 0.0002
274 VARICOSE VEIN 1 0.0002
275 POOR VENOUS ACCESS 2 0.0002
276 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
277 WEIGHT FLUCTUATION 2 0.0002
278 FOOD CRAVING 1 0.0002
279 BLOOD LACTIC ACID INCREASED 1 0.0002
280 INCONTINENCE 2 0.0002
281 ULCER 3 0.0002
282 SCIATICA 3 0.0002
283 FOOD POISONING 1 0.0002
284 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
285 INTESTINAL RESECTION 1 0.0002
286 BRUXISM 1 0.0002
287 PRODUCT RESIDUE PRESENT 1 0.0002
288 JAW DISORDER 1 0.0002
289 ON AND OFF PHENOMENON 1 0.0002
290 HEART RATE ABNORMAL 1 0.0002
291 ORAL PAIN 4 0.0002
292 SKIN INFECTION 2 0.0002
293 PRODUCT LEAKAGE 1 0.0002
294 PERIORBITAL SWELLING 1 0.0002
295 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
296 PAIN IN JAW 5 0.0002
297 CHOLECYSTECTOMY 2 0.0002
298 MYOCARDITIS 2 0.0002
299 MUSCULOSKELETAL DISCOMFORT 3 0.0002
300 CORONARY ARTERY BYPASS 1 0.0002
301 BLOOD URIC ACID INCREASED 1 0.0002
302 PRODUCT LABEL CONFUSION 1 0.0002
303 SPINAL PAIN 2 0.0002
304 URINE ODOUR ABNORMAL 1 0.0002
305 CATARACT OPERATION 1 0.0002
306 BLOOD POTASSIUM DECREASED 5 0.0002
307 GANGRENE 1 0.0002
308 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
309 FIBROMYALGIA 4 0.0002
310 NEURALGIA 4 0.0002
311 VULVOVAGINAL BURNING SENSATION 1 0.0002
312 MENISCUS INJURY 1 0.0002
313 NASAL DRYNESS 1 0.0002
314 FOOT FRACTURE 3 0.0002
315 PHOTOPSIA 1 0.0002
316 BLOOD URINE PRESENT 3 0.0002
317 HEAD INJURY 5 0.0002
318 POST PROCEDURAL COMPLICATION 3 0.0002
319 PROCTALGIA 1 0.0002
320 EAR PAIN 3 0.0002
321 HAEMORRHOIDS 3 0.0002
322 TENDON DISORDER 1 0.0002
323 NODULE 2 0.0002
324 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
325 POLYP 1 0.0002
326 IMMUNE SYSTEM DISORDER 2 0.0002
327 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
328 BACK PAIN 35 0.0002
329 SKIN MASS 1 0.0001
330 TERMINAL STATE 1 0.0001
331 FULL BLOOD COUNT DECREASED 3 0.0001
332 BRONCHIECTASIS 1 0.0001
333 METASTASES TO LYMPH NODES 1 0.0001
334 PRODUCTIVE COUGH 7 0.0001
335 RESPIRATION ABNORMAL 1 0.0001
336 HAIR GROWTH ABNORMAL 1 0.0001
337 ORAL DISCOMFORT 2 0.0001
338 APHONIA 2 0.0001
339 BLISTER 8 0.0001
340 DEVICE OCCLUSION 2 0.0001
341 HAND FRACTURE 1 0.0001
342 JOINT INJURY 3 0.0001
343 ARTHRITIS 11 0.0001
344 PANIC REACTION 1 0.0001
345 ANOSMIA 2 0.0001
346 FAECES SOFT 1 0.0001
347 RASH PUSTULAR 1 0.0001
348 SINUSITIS 14 0.0001
349 APPLICATION SITE PAIN 3 0.0001
350 CEREBRAL DISORDER 1 0.0001
351 CONTUSION 13 0.0001
352 TOOTH DISORDER 3 0.0001
353 PULMONARY MASS 2 0.0001
354 HYPOAESTHESIA ORAL 2 0.0001
355 FALL 44 0.0001
356 TENDON PAIN 1 0.0001
357 DEVICE FAILURE 2 0.0001
358 HIP ARTHROPLASTY 2 0.0001
359 THYROID DISORDER 2 0.0001
360 CONCUSSION 1 0.0001
361 PAIN IN EXTREMITY 38 0.0001
362 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
363 THERAPY PARTIAL RESPONDER 2 0.0001
364 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
365 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
366 OCULAR HYPERAEMIA 6 0.0001
367 MUSCULOSKELETAL STIFFNESS 11 0.0001
368 FRUSTRATION TOLERANCE DECREASED 1 0.0001
369 MUSCLE DISORDER 1 0.0001
370 FLATULENCE 7 0.0001
371 URINARY TRACT INFECTION 21 0.0001
372 POST PROCEDURAL INFECTION 1 0.0001
373 ABNORMAL FAECES 1 0.0001
374 METASTASES TO BONE 2 0.0001
375 HYPERAESTHESIA 1 0.0001
376 MENSTRUAL DISORDER 1 0.0001
377 BONE PAIN 7 0.0001
378 NASAL CONGESTION 7 0.0001
379 FLUID RETENTION 6 0.0001
380 CIRCULATORY COLLAPSE 2 0.0001
381 FACIAL PARALYSIS 1 0.0001
382 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
383 SKIN ULCER 3 0.0001
384 PARANOIA 2 0.0001
385 RESPIRATORY TRACT INFECTION 3 0.0001
386 DEVICE DISLOCATION 5 0.0001
387 LOCAL SWELLING 2 0.0001
388 DEVICE USE ISSUE 2 0.0001
389 GROIN PAIN 1 0.0001
390 SPINAL OSTEOARTHRITIS 1 0.0001
391 GRIP STRENGTH DECREASED 1 0.0001
392 COLD SWEAT 2 0.0001
393 MYOSITIS 1 0.0001
394 THERAPY NON-RESPONDER 5 0.0001
395 LIP DRY 1 0.0001
396 PNEUMONIA BACTERIAL 1 0.0001
397 INCREASED TENDENCY TO BRUISE 1 0.0001
398 PROCEDURAL PAIN 3 0.0001
399 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
400 FEELING COLD 3 0.0001
401 PERSONALITY CHANGE 1 0.0001
402 HAEMOPTYSIS 3 0.0001
403 THINKING ABNORMAL 2 0.0001
404 WOUND 3 0.0001
405 MIDDLE INSOMNIA 2 0.0001
406 DIARRHOEA HAEMORRHAGIC 1 0.0001
407 FLANK PAIN 1 0.0001
408 ARTERIOSCLEROSIS 1 0.0001
409 HALLUCINATION 8 0.0001
410 LEUKAEMIA 1 0.0001
411 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
412 ARTHRALGIA 44 0.0001
413 SPINAL DISORDER 1 0.0001
414 PRODUCT PACKAGING ISSUE 1 0.0001
415 LETHARGY 6 0.0001
416 LOWER LIMB FRACTURE 2 0.0001
417 PERIPHERAL SWELLING 16 0.0001
418 ATELECTASIS 1 0.0001
419 HERNIA 2 0.0001
420 NEEDLE ISSUE 3 0.0001
421 AUTOIMMUNE DISORDER 1 0.0001
422 RENAL TUBULAR NECROSIS 1 0.0001
423 THERAPY CHANGE 1 0.0001
424 BODY TEMPERATURE DECREASED 1 0.0001
425 HOSPICE CARE 1 0.0001
426 DISABILITY 2 0.0001
427 SINUS DISORDER 2 0.0001
428 CATARACT 6 0.0001
429 BLADDER DISORDER 1 0.0001
430 BLOOD PRESSURE ABNORMAL 2 0.0001
431 UPPER LIMB FRACTURE 2 0.0001
432 DEVICE ISSUE 9 0.0001
433 SPINAL FRACTURE 2 0.0001
434 EMPHYSEMA 1 0.0001
435 EYELID PTOSIS 1 0.0001
436 DRY THROAT 1 0.0001
437 DRUG LEVEL DECREASED 1 0.0001
438 MOTOR DYSFUNCTION 1 0.0001
439 SLUGGISHNESS 1 0.0001
440 INITIAL INSOMNIA 1 0.0001
441 EAR DISCOMFORT 1 0.0001
442 ILLNESS 10 0.0001
443 TEMPERATURE INTOLERANCE 1 0.0001
444 EYE DISCHARGE 1 0.0001
445 SWOLLEN TONGUE 3 0.0001
446 TENDERNESS 1 0.0001
447 PETECHIAE 1 0.0001
448 NERVOUSNESS 5 0.0001
449 KNEE ARTHROPLASTY 2 0.0001
450 SCRATCH 1 0.0001
451 RENAL PAIN 1 0.0001
452 RETCHING 2 0.0001
453 BREAST PAIN 1 0.0001
454 IMPAIRED WORK ABILITY 2 0.0001
455 HEREDITARY ANGIOEDEMA 1 0.0001
456 COUGH 26 0.0001
457 SKIN LACERATION 1 0.0001
458 BACK INJURY 1 0.0001
459 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
460 PAIN 56 0.0001
461 TOOTH FRACTURE 1 0.0001
462 SKIN DISORDER 3 0.0001
463 OCULAR DISCOMFORT 1 0.0001
464 HEART RATE IRREGULAR 2 0.0001
465 APPLICATION SITE PRURITUS 2 0.0001
466 IMPAIRED DRIVING ABILITY 1 0.0001
467 MICTURITION URGENCY 1 0.0001
468 METASTASES TO LUNG 1 0.0001
469 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
470 DRY MOUTH 7 0.0001
471 BURNING SENSATION 6 0.0001
472 COVID-19 PNEUMONIA 1 0.0001
473 WHEEZING 5 0.0001
474 BACTERAEMIA 1 0.0001
475 PRODUCT ADHESION ISSUE 3 0.0001
476 ACCIDENT 1 0.0001
477 MULTIPLE SCLEROSIS 4 0.0001
478 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
479 HEPATITIS C 1 0.0001
480 DRUG EFFECT INCOMPLETE 3 0.0001
481 MYALGIA 14 0.0001
482 PANIC ATTACK 3 0.0001
483 MUSCLE SPASMS 15 0.0001
484 LUNG DISORDER 4 0.0001
485 PRODUCT DOSE OMISSION ISSUE 24 0.0001
486 NASOPHARYNGITIS 15 0.0001
487 SMALL INTESTINAL OBSTRUCTION 1 0.0001
488 BRONCHITIS 6 0.0001
489 PHARYNGITIS 1 0.0001
490 CYST 1 0.0001
491 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
492 CONFUSIONAL STATE 13 0.0001
493 APPLICATION SITE IRRITATION 1 0.0001
494 AGEUSIA 2 0.0001
495 PNEUMONIA ASPIRATION 2 0.0001
496 INTENTIONAL PRODUCT MISUSE 7 0.0001
497 DYSPNOEA EXERTIONAL 3 0.0001
498 SOMNOLENCE 16 0.0001
499 CELLULITIS 4 0.0001
500 CARDIOVASCULAR DISORDER 2 0.0001
501 THERAPY CESSATION 4 0.0001
502 ABDOMINAL DISCOMFORT 13 0.0001
503 UNRESPONSIVE TO STIMULI 2 0.0001
504 RHINORRHOEA 5 0.0001
505 HIATUS HERNIA 1 0.0001
506 ASTHENIA 29 0.0001
507 SEDATION 2 0.0001
508 MUSCULOSKELETAL PAIN 4 0.0001
509 APPLICATION SITE ERYTHEMA 2 0.0001
510 INCORRECT PRODUCT STORAGE 1 0.0001
511 GASTRITIS 2 0.0001
512 ORAL CANDIDIASIS 1 0.0001
513 SARS-COV-2 TEST POSITIVE 1 0.0001
514 DEPRESSED MOOD 4 0.0001
515 DYSMENORRHOEA 1 0.0001
516 ADVERSE REACTION 1 0.0001
517 EYE HAEMORRHAGE 1 0.0001
518 HAIR TEXTURE ABNORMAL 1 0.0001
519 QUALITY OF LIFE DECREASED 1 0.0001
520 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
521 FATIGUE 58 0.0001
522 DEVICE BREAKAGE 3 0.0001
523 PNEUMONITIS 2 0.0001
524 DRUG TOXICITY 1 0.0001
525 IMPAIRED GASTRIC EMPTYING 1 0.0001
526 ABDOMINAL PAIN UPPER 15 0.0001
527 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
528 ABNORMAL DREAMS 2 0.0001
529 DIVERTICULITIS 2 0.0001
530 MENTAL STATUS CHANGES 2 0.0001
531 ARTHROPATHY 4 0.0001
532 WEIGHT DECREASED 20 0.0001
533 CARPAL TUNNEL SYNDROME 1 0.0001
534 DIARRHOEA 46 0.0001
535 INTENTIONAL DOSE OMISSION 2 0.0001
536 BRONCHOSPASM 1 0.0001
537 RED BLOOD CELL COUNT DECREASED 2 0.0001
538 IMPAIRED QUALITY OF LIFE 1 0.0001
539 PARAESTHESIA ORAL 1 0.0001
540 PANCREATIC CARCINOMA 2 0.0001
541 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
542 APATHY 1 0.0001
543 DYSPHONIA 4 0.0001
544 CHEST DISCOMFORT 7 0.0001
545 ASCITES 2 0.0001
546 PNEUMONIA 22 0.0001
547 ACUTE MYOCARDIAL INFARCTION 2 0.0001
548 LIVER DISORDER 3 0.0001
549 SKIN HAEMORRHAGE 1 0.0001
550 COLON CANCER 1 0.0001
551 HEADACHE 42 0.0001
552 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
553 RESPIRATORY DISORDER 2 0.0001
554 FEELING ABNORMAL 16 0.0001
555 JOINT SWELLING 8 0.0001
556 STOMATITIS 4 0.0001
557 OSTEOPENIA 1 0.0001
558 URTICARIA 11 0.0001
559 DISCOMFORT 4 0.0001
560 SKIN DISCOLOURATION 3 0.0001
561 DEVICE RELATED INFECTION 1 0.0001
562 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
563 EMOTIONAL DISORDER 2 0.0001
564 LIMB DISCOMFORT 2 0.0001
565 FEMUR FRACTURE 2 0.0001
566 DELUSION 1 0.0001
567 SWELLING 6 0.0001
568 BASAL CELL CARCINOMA 1 0.0001
569 PRODUCT USE COMPLAINT 1 0.0001
570 NEUROPATHY PERIPHERAL 6 0.0001
571 RESPIRATORY TRACT CONGESTION 1 0.0001
572 HALLUCINATION, AUDITORY 1 0.0001
573 CYSTITIS 2 0.0001
574 INFLUENZA 7 0.0001
575 GAIT DISTURBANCE 12 0.0001
576 PRURITUS 24 0.0001
577 SENSORY DISTURBANCE 1 0.0001
578 HIP FRACTURE 2 0.0001
579 NIGHT SWEATS 2 0.0001
580 BLOOD POTASSIUM INCREASED 1 0.0001
581 DYSPEPSIA 6 0.0001
582 EYE DISORDER 2 0.0001
583 INFLUENZA LIKE ILLNESS 5 0.0001
584 STAPHYLOCOCCAL INFECTION 2 0.0001
585 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
586 DRY EYE 3 0.0001
587 LIP SWELLING 2 0.0001
588 RENAL IMPAIRMENT 5 0.0001
589 TYPE 2 DIABETES MELLITUS 2 0.0001
590 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
591 HEMIPARESIS 1 0.0001
592 GASTRIC DISORDER 2 0.0001
593 INFLAMMATION 3 0.0001
594 DEVICE DEFECTIVE 1 0.0001
595 DELIRIUM 2 0.0001
596 METASTASES TO LIVER 1 0.0001
597 LYMPHOCYTE COUNT DECREASED 1 0.0001
598 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
599 ISCHAEMIC STROKE 1 0.0001
600 SKIN BURNING SENSATION 4 0.0001
601 GASTROENTERITIS VIRAL 1 0.0001
602 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
603 INFECTION 8 0.0001
604 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
605 END STAGE RENAL DISEASE 1 0.0001
606 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
607 OROPHARYNGEAL PAIN 5 0.0001
608 DYSGEUSIA 4 0.0001
609 HEPATIC FUNCTION ABNORMAL 2 0.0001
610 EPISTAXIS 4 0.0001
611 OXYGEN SATURATION DECREASED 3 0.0001
612 HEPATIC CIRRHOSIS 1 0.0001
613 HOT FLUSH 4 0.0001
614 INTESTINAL OBSTRUCTION 2 0.0001
615 BLOOD SODIUM DECREASED 1 0.0001
616 RHEUMATOID ARTHRITIS 6 0.0001
617 FRACTURE 1 0.0001
618 MUSCULAR WEAKNESS 6 0.0001
619 COLITIS 2 0.0001
620 INSOMNIA 14 0.0001
621 MUSCULOSKELETAL DISORDER 1 0.0001
622 SLEEP APNOEA SYNDROME 1 0.0001
623 MIGRAINE 5 0.0001
624 INCREASED APPETITE 1 0.0001
625 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
626 CHOLESTASIS 1 0.0001
627 DRUG PRESCRIBING ERROR 1 0.0001
628 ACUTE RESPIRATORY FAILURE 1 0.0001
629 ERUCTATION 1 0.0001
630 PRESCRIBED OVERDOSE 1 0.0001
631 DECREASED APPETITE 12 0.0001
632 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
633 SKIN FISSURES 1 0.0001
634 VISION BLURRED 7 0.0001
635 KIDNEY INFECTION 1 0.0001
636 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
637 HEART RATE INCREASED 5 0.0001
638 CONSTIPATION 11 0.0001
639 HAEMATOCRIT DECREASED 1 0.0001
640 PRESCRIBED UNDERDOSE 1 0.0001
641 SYNCOPE 5 0.0000
642 PRODUCT ADMINISTRATION ERROR 1 0.0000
643 FEEDING DISORDER 1 0.0000
644 OEDEMA PERIPHERAL 6 0.0000
645 DYSKINESIA 2 0.0000
646 BODY TEMPERATURE INCREASED 1 0.0000
647 PRODUCT PREPARATION ERROR 1 0.0000
648 CHEST PAIN 9 0.0000
649 VISUAL IMPAIRMENT 6 0.0000
650 PERITONITIS 1 0.0000
651 TREMOR 8 0.0000
652 PULMONARY HYPERTENSION 1 0.0000
653 ROAD TRAFFIC ACCIDENT 2 0.0000
654 DERMATITIS 1 0.0000
655 HYPERTENSION 10 0.0000
656 OSTEOARTHRITIS 2 0.0000
657 PLATELET COUNT DECREASED 5 0.0000
658 HYPOAESTHESIA 7 0.0000
659 LIVER FUNCTION TEST INCREASED 1 0.0000
660 POOR QUALITY SLEEP 1 0.0000
661 DEEP VEIN THROMBOSIS 3 0.0000
662 FAECES DISCOLOURED 1 0.0000
663 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
664 COVID-19 8 0.0000
665 DEHYDRATION 6 0.0000
666 SNEEZING 1 0.0000
667 PANCREATITIS ACUTE 1 0.0000
668 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
669 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
670 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
671 CHROMATURIA 1 0.0000
672 DYSPNOEA 25 0.0000
673 DIZZINESS 22 0.0000
674 PRODUCT AVAILABILITY ISSUE 1 0.0000
675 NEPHROLITHIASIS 2 0.0000
676 PYREXIA 15 0.0000
677 RENAL DISORDER 2 0.0000
678 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
679 COGNITIVE DISORDER 2 0.0000
680 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
681 CARDIAC DISORDER 4 0.0000
682 PALPITATIONS 5 0.0000
683 CHILLS 5 0.0000
684 SLEEP DISORDER 3 0.0000
685 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
686 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
687 MOBILITY DECREASED 3 0.0000
688 HEPATIC CANCER 1 0.0000
689 ENCEPHALOPATHY 1 0.0000
690 HYPOTENSION 8 0.0000
691 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
692 DEPRESSION 9 0.0000
693 PRODUCT COMPLAINT 1 0.0000
694 DIABETES MELLITUS 3 0.0000
695 BLOOD PRESSURE INCREASED 6 0.0000
696 INJECTION SITE SWELLING 3 0.0000
697 HYPOPHAGIA 1 0.0000
698 LOSS OF CONSCIOUSNESS 5 0.0000
699 HAEMOGLOBIN DECREASED 4 0.0000
700 ERECTILE DYSFUNCTION 1 0.0000
701 HYPERHIDROSIS 5 0.0000
702 ANAPHYLACTIC SHOCK 1 0.0000
703 ABDOMINAL PAIN 9 0.0000
704 HAEMATOMA 1 0.0000
705 DIPLOPIA 1 0.0000
706 ABDOMINAL DISTENSION 4 0.0000
707 HAEMORRHAGE 4 0.0000
708 DEAFNESS 1 0.0000
709 SPEECH DISORDER 2 0.0000
710 HYPERSENSITIVITY 7 0.0000
711 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
712 INJECTION SITE BRUISING 3 0.0000
713 EAR INFECTION 1 0.0000
714 CARDIAC FAILURE 3 0.0000
715 BLOOD GLUCOSE INCREASED 7 0.0000
716 PAIN OF SKIN 1 0.0000
717 FREQUENT BOWEL MOVEMENTS 1 0.0000
718 BLOOD BILIRUBIN INCREASED 1 0.0000
719 THROAT TIGHTNESS 1 0.0000
720 RASH PRURITIC 2 0.0000
721 OEDEMA 2 0.0000
722 RASH 16 0.0000
723 ANAEMIA 7 0.0000
724 MOOD ALTERED 1 0.0000
725 NAUSEA 29 0.0000
726 HAEMATOCHEZIA 2 0.0000
727 RESPIRATORY DISTRESS 1 0.0000
728 SEPSIS 4 0.0000
729 WEIGHT INCREASED 8 0.0000
730 SKIN EXFOLIATION 3 0.0000
731 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
732 ASTHMA 4 0.0000
733 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
734 EYE IRRITATION 2 0.0000
735 BALANCE DISORDER 3 0.0000
736 DYSSTASIA 1 0.0000
737 MALAISE 15 0.0000
738 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
739 ERYTHEMA 7 0.0000
740 PSYCHOTIC DISORDER 1 0.0000
741 DISEASE PROGRESSION 4 0.0000
742 URINARY INCONTINENCE 1 0.0000
743 RENAL INJURY 1 0.0000
744 GASTROINTESTINAL DISORDER 3 0.0000
745 HEPATIC FAILURE 1 0.0000
746 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
747 PLEURAL EFFUSION 2 0.0000
748 VERTIGO 2 0.0000
749 FEELING HOT 2 0.0000
750 DRUG ADMINISTRATION ERROR 1 0.0000
751 NERVOUS SYSTEM DISORDER 1 0.0000
752 PRODUCT USE ISSUE 6 0.0000
753 VOMITING 15 0.0000
754 DRUG INEFFECTIVE 42 0.0000
755 ANXIETY 9 0.0000
756 DYSPHAGIA 3 0.0000
757 MOVEMENT DISORDER 1 0.0000
758 AMNESIA 2 0.0000
759 SWELLING FACE 2 0.0000
760 VISUAL ACUITY REDUCED 1 0.0000
761 BLOOD PRESSURE DECREASED 2 0.0000
762 EXPIRED PRODUCT ADMINISTERED 1 0.0000
763 VIRAL INFECTION 1 0.0000
764 FUNGAL INFECTION 1 0.0000
765 URINARY RETENTION 1 0.0000
766 GAIT INABILITY 1 0.0000
767 INJECTION SITE PRURITUS 2 0.0000
768 FLUSHING 3 0.0000
769 NEUTROPENIA 4 0.0000
770 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
771 NIGHTMARE 1 0.0000
772 DEVICE USE ERROR 1 0.0000
773 NEOPLASM PROGRESSION 1 0.0000
774 HYPERKALAEMIA 1 0.0000
775 LYMPHADENOPATHY 1 0.0000
776 THERAPY INTERRUPTED 2 0.0000
777 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
778 C-REACTIVE PROTEIN INCREASED 1 0.0000
779 HYPERGLYCAEMIA 1 0.0000
780 DYSURIA 1 0.0000
781 EYE SWELLING 1 0.0000
782 THROMBOCYTOPENIA 3 0.0000
783 DYSARTHRIA 1 0.0000
784 ACNE 2 0.0000
785 CHRONIC KIDNEY DISEASE 2 0.0000
786 CONDITION AGGRAVATED 8 0.0000
787 ACUTE KIDNEY INJURY 4 0.0000
788 INJECTION SITE PAIN 8 0.0000
789 SEIZURE 3 0.0000
790 INJECTION SITE HAEMORRHAGE 2 0.0000
791 THROMBOSIS 2 0.0000
792 EXTRA DOSE ADMINISTERED 1 0.0000
793 BLINDNESS 1 0.0000
794 OSTEOPOROSIS 1 0.0000
795 DRUG DOSE OMISSION 4 0.0000
796 INJECTION SITE ERYTHEMA 3 0.0000
797 OFF LABEL USE 21 0.0000
798 POLLAKIURIA 1 0.0000
799 WITHDRAWAL SYNDROME 1 0.0000
800 CEREBROVASCULAR ACCIDENT 4 0.0000
801 RECTAL HAEMORRHAGE 1 0.0000
802 DEVICE LEAKAGE 1 0.0000
803 SEPTIC SHOCK 1 0.0000
804 MENTAL DISORDER 1 0.0000
805 PSORIASIS 3 0.0000
806 DRY SKIN 3 0.0000
807 COLITIS ULCERATIVE 1 0.0000
808 PULMONARY OEDEMA 1 0.0000
809 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
810 THROAT IRRITATION 1 0.0000
811 ADVERSE DRUG REACTION 2 0.0000
812 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
813 INCORRECT DOSE ADMINISTERED 5 0.0000
814 SUICIDAL IDEATION 2 0.0000
815 MEMORY IMPAIRMENT 3 0.0000
816 TINNITUS 1 0.0000
817 BREAST CANCER 2 0.0000
818 BLOOD CHOLESTEROL INCREASED 1 0.0000
819 PULMONARY EMBOLISM 2 0.0000
820 DISEASE RECURRENCE 1 0.0000
821 RASH ERYTHEMATOUS 1 0.0000
822 BLOOD GLUCOSE DECREASED 1 0.0000
823 INTERSTITIAL LUNG DISEASE 1 0.0000
824 ATRIAL FIBRILLATION 2 0.0000
825 LEUKOPENIA 1 0.0000
826 AGGRESSION 1 0.0000
827 DEATH 17 0.0000
828 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
829 ECZEMA 1 0.0000
830 PARAESTHESIA 3 0.0000
831 DERMATITIS ATOPIC 1 0.0000
832 DRUG EFFECT DECREASED 1 0.0000
833 TREATMENT NONCOMPLIANCE 1 0.0000
834 HYPONATRAEMIA 1 0.0000
835 EYE PAIN 1 0.0000
836 HERPES ZOSTER 1 0.0000
837 PRODUCT SUBSTITUTION ISSUE 1 0.0000
838 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
839 MYOCARDIAL INFARCTION 3 0.0000
840 IRRITABILITY 1 0.0000
841 THERAPEUTIC RESPONSE DECREASED 1 0.0000
842 ILL-DEFINED DISORDER 1 0.0000
843 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
844 INTENTIONAL OVERDOSE 1 0.0000
845 PRODUCT DOSE OMISSION 1 0.0000
846 DEVICE DIFFICULT TO USE 1 0.0000
847 HEPATIC ENZYME INCREASED 1 0.0000
848 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
849 INJECTION SITE REACTION 1 0.0000
850 DEVICE MALFUNCTION 1 0.0000
851 INJURY 1 0.0000
852 UNDERDOSE 1 0.0000
853 AGITATION 1 0.0000
854 UNEVALUABLE EVENT 1 0.0000
855 DRUG INTERACTION 2 0.0000
856 CARDIAC ARREST 1 0.0000
857 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
858 PRODUCT STORAGE ERROR 1 0.0000
859 TACHYCARDIA 1 0.0000
860 ADVERSE EVENT 1 0.0000
861 DRUG INTOLERANCE 1 0.0000
862 ALOPECIA 2 0.0000
863 OVERDOSE 2 0.0000
864 RENAL FAILURE 1 0.0000
865 PRODUCT QUALITY ISSUE 1 0.0000
866 HOSPITALISATION 1 0.0000
867 NO ADVERSE EVENT 1 0.0000